Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6236-6243

  Shields, Philip L ^a   Morland, Clare M ^a   Salmon, Michael ^a   Qin, Shixin ^b   Hubscher, Stefan G ^a   Adams, David H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER SINUSOID; LYMPHOCYTIC INFILTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION;

CELL MOVEMENT; CHEMOKINES; CHEMOKINES, CXC; ENDOTHELIUM, VASCULAR; HEPATITIS C, CHRONIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; KUPFFER CELLS; LIVER; PORTAL VEIN; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033485942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Seeff, L. B. 1997. Natural history of hepatitis C. Hepatology 26.-21S.
2. Adams, D. H., and S. Shaw. 1994. Leucocyte endothelial interactions and regulation of leucocyte migration. Lancet 343:831.
3. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
4. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
5. Adams, D. H., and A. R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349:490.
6. Luster, A. D. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
7. Mackay, C. R. 1996. Chemokine receptors and T-cell chemotaxis. J. Exp. Med. 184:799.
8. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
9. Campbell, J. J., S. X. Qin, K. B. Bacon, C. R. Mackay, and E. C. Butcher. 1996. Biology of chemokine and classical chemoattractant receptors - differential requirements for adhesion-triggering versus chemotactic responses in lymphoid-cells. J. Cell Biol. 134:255.
10. 2 integrins on T-lymphocytes. Immunity 4:179.
11. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
12. Taub, D. D., S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy. 1996. Chemokines and T lymphocyte activation. I. β chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095.
13. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T-cell signaling pathways by the chemokine RANTES. Science 269:1727.
14. Tanaka, Y., K. Kimata, D. H. Adams, and S. Eto. 1998. Modulation of cytokine function by proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc. Assoc. Am. Phys. 110:118.
15. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
16. Siveke, J. T., and A. Hamann. 1998. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:550.
17. Larsen, C. G., A. O. Anderson, E. Appella, J. J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464.
18. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber. 1995. Human Mig chemokine - biochemical and functional characterization. J. Exp. Med. 182:1301.
19. Taub, D. D., D. L. Longo, and W. J. Murphy. 1996. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T-lymphocytes into the peripheral-tissues of human peripheral-blood lymphocytes-scid mice. Blood 87:1423.
20. Farber, J. M. 1993. HuMig: a new human member of the chemokine family of cytokines. Biochem. Biophys. Res. Commun. 192: 223.
21. Tsai, S. L., Y. F. Liaw, M. H. Chen, C. Y. Huang, and G. C. Kuo. 1997. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 7: 449.
22. Woitas, R. P., M. Lechmann, G. Jung, R. Kaiser, T. Sauerbruch, and U. Spengler. 1997. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J. Immunol. 159:1012.
23. Napoli, J., G. A. Bishop, P. H. McGuinness, D. M. Painter, and G. W. McCaughan. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759.
24. Dumoulin, F. L., A. Bach, L. Leifeld, M. El-Bakri, H. P. Fischer, T. Sauerbruch, and U. Spengler. 1997. Semiquantitative analysis of intrahepatic cytokines mRNA in chronic hepatitis C. J. Infect. Dis. 175: 681.
25. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006.
26. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
27. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746.
28. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344.
29. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loetscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836.
30. Joplin, R., T. Hishida, H. Tsubouchi, Y. Diakuhara, R. C. S. Ayres, J. M. Neuberger, and A. J. Strain. 1992. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J. Clin. Invest. 90:1284.
31. Adams, D. H., S. G. Hubscher, N. C. Fisher, A. Williams, and M. Robinson. 1996. Expression of E-selectin (CD62E) and E-selectin ligands in human liver inflammation. Hepatology 24:533.
32. Adams, D. H., S. G. Hubscher, J. Shaw, G. D. Johnson, C. Babbs, R. Rothlein, and J. M. Neuberger. 1991. Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary scelrosing cholangitis. Hepatology 14:426.
33. Salmon, M., D. Scheel-Toellner, A. P. Huissoon, D. Pilling, N. Shamsadeen, H. Hyde, A. D. d'Angeac, P. A. Bacon, P. Emery, and A. N. Akbar. 1997. Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99:439.
34. Yoong, K. F., G. McNab, S. G. Hubscher, and D. H. Adams. 1998. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J. Immunol. 160:3978.
35. Morland, C. M., J. Fear, G. McNab, R. Joplin, and D. H. Adams. 1997. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc. Assoc. Am. Phys. 109:372.
36. Chomsczynzki, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guadinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
37. Yap, S. H., M. Willems, J. Van den Oord, W. Habets, J. M. Middeldorp, J. A. Hellings, F. Nevens, H. Moshage, V. Desmet, and J. Fevery. 1994. Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. J. Hepatol. 20:275.
38. Chisari, F. V. 1997. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 99:1472.
39. Ebnet, K., M. M. Simon, and S. Shaw. 1996. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi. Ann. NY Acad. Sci. 797:107.
40. Piali, L., C. Weber, G. Larosa, C. R. Mackay, T. A. Springer, I. Clark-Lewis, and B. Moser. 1998. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 28:961.
41. Nelson, D. R., H. L. Lim, C. G. Marousis, J. W. Fang, G. L. Davis, L. Shen, M. S. Urdea, J. A. Kolberg, and J. Y. Lau. 1997. Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42:2487.
42. Zylberberg, H., A. C. Rimaniol, S. Pol, A. Masson, D. De Groote, P. Berthelot, J. F. Bach, C. Brechot, and F. Zavala. 1999. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30:185.
43. Kallinowski, B., K. Haseroth, G. Marinos, C. Hanck, W. Stremmel, L. Theilmann, M. V. Singer, and S. Rossol. 1998. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin. Exp. Immunol. 111:269.
44. Itoh, Y., T. Okanoue, N. Ohnishi, M. Sakamoto, K. Nishioji, Y. Nakagawa, M. Minami, Y. Murakami, and K. Kashima. 1999. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 94:1332.
45. Yoshioka, K., S. Kakumu, M. Arao, Y. Tsutsumi, M. Inoue, T. Wakita, T. Ishikawa, and M. Mizokami. 1990. Immunohistochemical studies of intrahepatic tumour necrosis factor a in chronic liver disease. J. Clin. Pathol. 43:298.
46. Narumi, S., Y. Tominaga, M. Tamaru, S. Shimai, H. Okumura, K. Nishioji, Y. Itoh, and T. Okanoue. 1997. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 158:5536.
47. Norris, S., C. Collins, D. O. Doherty, F. Smith, G. McEntee, O. Traynor, N. Nolan, J. Hegarty, and C. O'Farrelly. 1998. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28: 84.
48. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
49. Salmi, M., D. H. Adams, and S. Jalkanen. 1998. Lymphocyte trafficking in the intestine and liver. Am. J. Physiol. 274:1.
50. Crispe, N. I., and W. Z. Mehal. 1996. Strange brew: T cells in the liver. Immunol. Today 17:522.
51. Afford, S. C., S. Hubscher, A. J. Strain, D. H. Adams, and J. M. Neuberger. 1995. Apoptosis in the human liver during allograft-rejection and end-stage liver-disease. J. Pathol. 176:373.
52. Jaeschke, H., and C. W. Smith. 1997. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature. Am. J. Physiol. 273:G1169.
53. Hubscher, S. G. 1998. Histological grading and staging in chronic hepatitis: clinical applications and problems. J. Hepatol. 29:1015.
54. Kay, E. W., J. O'Dowd, R. Thomas, R. Alyusuf, S. Sachithanandan, R. Robinson, C. B. Walsh, J. F. Fielding, and M. B. Leader. 1997. Mild abnormalities in liver histology associated with chronic hepatitis: distinction from normal liver histology. J. Clin. Pathol. 50:929.
55. Afford, S. C., N. C. Fisher, D. A. H. Neil, J. Fear, P. Brun, S. G. Hubscher, and D. H. Adams. 1998. Distinct patterns of chemokine expression are associated with leucocyte recruitment in alcoholic hepatitis & alcoholic cirrhosis. J. Pathol. 186:82.
56. Ishak, K., A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, H. Denk, V. Desmet, G. Korb, and R. N. MacSween. 1995. Histological grading and staging of chronic hepatitis. J. Hepatol. 22:696.
57. Cooksley, W. G., R. A. Bradbear, W. Robinson, M. Harrison, J. W. Halliday, L. W. Powell, H. S. Ng, C. S. Seah, K. Okuda, and P. J. Scheuer. 1986. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 6:345.
58. Bedossa, P., and T. Poynard. 1996. An algorithm for the grading of activity in chronic hepatitis C: the METAVIR Cooperative Study Group. Hepatology 24: 289.
59. Scheuer, P. J., K. Krawczynski, and A. P. Dhillon. 1997. Histopathology and detection of hepatitis C virus in liver. Springer Semin. Immunopathol. 19:27.
60. Yoong, K. F., S. C. Afford, R. Jones, P. Aujla, S. Qin, K. Price, S. G. Hubscher, and D. H. Adams. 1999. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by γ-interferon in lymphocyte recruitment to hepatocellular carcenoma. Hepatology 30: 100.